NASHVILLE, Tenn. (WSMV) - A group of news organizations is suing Tennessee’s Department of Corrections commissioner and a prison warden over the limitations the state’s execution methods present to ...
A newer tool used to assess cardiovascular disease risk comes with both answers…and some questions. “These results were not surprising to us,” investigators Adam Bress, PharmD, MS, and Catherine ...
Dealing with unexpected gray hair can be confusing. Yes, it’s a natural part of the aging process (and there are so many chic ways to let it grow out, it can even be a welcome change), but when you’re ...
My beloved grandmother Evelyn lived independently into her 90s. She clutched my arm tightly at every visit, sharing her terror that she would lose her prodigious ...
Please provide your email address to receive an email when new articles are posted on . AHA and ACC unveiled a companion document to their recently published hypertension guideline. The document ...
With the latest US guidelines for blood pressure management being the first to recommend using the novel PREVENT calculator to assess patient risk, the American Heart Association (AHA) and American ...
The European Commission has granted marketing authorization for Gilead Sciences' twice-yearly injection for preventing HIV infection, the company said on Tuesday. Story by Eliza Herbert. Largest Home ...
Lenacapavir approved for PrEP in EU, Norway, Iceland, Liechtenstein Pricing, reimbursement to be determined with each country Gilead's lenacapavir nearly 100% effective in trials Aug 26 (Reuters) - ...
What Is Alhemo, and Why Does It Matter? Alhemo (concizumab-mtci) is a medicine approved to help prevent bleeding in people aged 12 or older with hemophilia A or B who don’t have inhibitors to certain ...
If you’ve logged into your WordPress dashboard and seen the warning that your site is running on PHP 7.4.33, you’re not alone. This outdated version no longer receives security updates, which makes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results